O fio das notícias do Brasil

Receba as notícias no WhatsApp

Rio resumes mpox vaccination, but Brazil negotiates only 25,000 doses for people living with HIV

City receives 1,000 vials from the Health Ministry and resumes immunization; number negotiated with PAHO falls far short of what is needed.

Por O Fio

This is a translation of the original article in Portuguese. Read the original (Português).

The Municipal Health Department of Rio de Janeiro has resumed mpox vaccination after receiving 1,000 vials from Brazil’s Health Ministry, a quantity that allows up to 5,000 doses to be given. The campaign had been suspended due to a lack of stock, according to the Brazilian newspaper O Dia.

Vaccination covers people who use PrEP, pre-exposure prophylaxis against HIV, and people living with HIV whose CD4 count is below 200, an indicator that measures the body’s defenses. With limited stock, the volume received by the city should cover only part of this population.

The scale of the problem is evident at the national level. According to former municipal health secretary and current federal lawmaker Daniel Soranz, speaking to O Dia, Brazil is negotiating only 25,000 doses through the Pan American Health Organization (PAHO). To immunize people living with HIV, between 1.7 million and 1.9 million doses would be needed. In other words, what is under negotiation represents just over 1% of what is needed, based on the lower estimate.

Soranz says the country has the capacity to produce the vaccine on its own. Today, the vaccine is supplied by a single manufacturer, which leaves the public health system dependent on one source and subject to delays and small delivery quotas. The lawmaker argues that domestic production would be the way to guarantee a steady supply.

The lawmaker also estimates that the current outbreak should pass within two months. That forecast, however, does not eliminate the need to protect those at greatest risk of complications while the virus continues to circulate.

For readers, what changes immediately is that in Rio the vaccine is available again for priority groups, although in limited quantities. Those who meet the criteria should go to the municipal health network. The prospect of a broader supply, however, depends on new shipments and on federal government decisions about purchasing or production.

Reporting from O Dia (p. 4, editoria Rio de Janeiro/RJ: Rio retoma vacinação contra mpox após falta de estoque), O Dia (p. 4, editoria Nacional: Daniel Soranz defende produção de vacina contra mpox no Brasil).

Esta matéria reúne informações publicadas pelos veículos citados acima, com edição da redação do O Fio. Conheça nossa política editorial. Encontrou um erro? Fale com a redação.

Deixe um comentário

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *

Os comentários passam por moderação antes de aparecer. Seu e-mail não é publicado. Ofensas, ataques pessoais e propaganda são removidos. Veja a política de privacidade.